Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.trimurthidrugs.com | |
Market Cap | 9.07 Cr. | |
Enterprise Value(EV) | 9.07 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.19 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 82.98 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 8.59 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.30 | Calculated using Price: 11.20 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.81 Cr. | 8,100,000 Shares |
FaceValue | 10 | |
About Trimurthi Ltd. | ||
Trimurthi Drugs & Pharmaceuticals is an India-based company. The Company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products. The Company's range of products include antibiotics, anti ulcer, anti inflammatory, antitussive/expectorant, cardiovascular, anti fungal, anti retroviral drugs, syrups and protein powder. The company since 1976 is built on the philosophy of commitment to quality and responsiveness. |
1 Day |
|
-4.68% |
1 Week |
|
+9.16% |
1 Month |
|
+40.0% |
3 Month |
|
+27.71% |
6 Month |
|
+12.00% |
1 Year |
|
+38.10% |
2 Year |
|
+86.67% |
5 Year |
|
+60.0% |
10 Year |
|
-6.28% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 0.16 | 0.86 | 1.31 | 1.55 | 2.10 | 0.79 | -31.32 | -19.45 | -0.83 | |
Return on Capital Employed (%) | 0.81 | 1.20 | 1.78 | 2.50 | 1.60 | 0.89 | -31.33 | -19.51 | -0.81 | |
Return on Assets (%) | 0.16 | 0.85 | 1.29 | 1.50 | 2.04 | 0.78 | -31.42 | -19.56 | -0.83 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 11 | 11 | 12 | 12 | 12 | 12 | 9 | 7 | 7 | 7 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 12 | 12 | 12 | 12 | 12 | 12 | 9 | 7 | 7 | 7 | |
Non Curr. Assets | 2 | 2 | 3 | 4 | 3 | 4 | 4 | 3 | 3 | 3 | |
Curr. Assets | 9 | 9 | 9 | 9 | 9 | 8 | 5 | 5 | 4 | 4 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 12 | 12 | 12 | 12 | 12 | 12 | 9 | 7 | 7 | 7 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 1 | 1 | 4 | 3 | 4 | 1 | 1 | 1 | 1 | 4 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||
Total Income | 1 | 1 | 4 | 3 | 4 | 2 | 1 | 1 | 2 | 5 | |
Total Expenditure | -1 | -1 | -3 | -3 | -3 | -1 | -5 | -3 | -2 | -5 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | -3 | -1 | 0 | ||
Interest | |||||||||||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | -3 | -2 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | -4 | -2 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 2 | -1 | 1 | 0 | 1 | 1 | 1 | 0 | |
Cash Fr. Inv. | 1 | 0 | -2 | 1 | -1 | 0 | 0 | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | |||||||||
Net Change | 1 | -1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | |
Cash & Cash Eqvt | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 3 |
Fri, 08 Dec 2023
Board Meeting Intimation for Un-Audited Consolidated Results For The Quarter Ended 31.12.2022 Trimurthi Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/12/2023 inter alia to consider and approve Results |
Fri, 24 Nov 2023
Consolidated Financial Results For The Quarter Ended 31.12.2022 Consolidated financial results for the quarter ended 31.12.2022 |
Thu, 19 Oct 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Paper ad for un-audited financial results |
Mon, 11 Dec 2023 |
|
|
|
|
|